青松股份(300132.SZ):全資子公司取得6項實用新型專利
格隆匯3月20日丨青松股份(300132.SZ)公佈,公司全資子公司福建南平龍晟香精香料有限公司、福建南平青松化工有限公司近日收到了國家知識產權局頒發的6項《實用新型專利證書》,涉具有過濾除雜結構的乙酸苄酯粗品除鹽裝置;一種具有緩衝機構的酯化反應釜;一種便於操作的乙酸苄酯製備用預酯化反應釜;具有冷凝回收功能的含水丁酮脱水裝置;自動計量添料的龍涎酮縮合釜;合成樟腦生產用昇華裝置。
上述專利的取得不會對公司目前生產經營情況產生重大影響,但有利於公司進一步完善知識產權保護體系,形成持續創新機制。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.